Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Commentar zur Pharmacopoea Germanica | Statement: [Hermann Hager, notableWork, Commentar zur Pharmacopoea Germanica]

Target entity: Commentar zur Pharmacopoea Germanica
Context triple: [Hermann Hager, notableWork, Commentar zur Pharmacopoea Germanica]

• A. Certificates of Suitability to the monographs of the European Pharmacopoeia
  Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
• B. European Pharmacopoeia
  The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
• C. Pharmacopeia
  Pharmacopeia is a biotechnology company known for pioneering combinatorial chemistry and high-throughput drug discovery technologies.
• D. United States Pharmacopeia
  The United States Pharmacopeia is an official compendium that sets quality, purity, strength, and identity standards for medicines, food ingredients, and dietary supplements used in the United States and many other countries.
• E. Japanese Pharmacopoeia
  The Japanese Pharmacopoeia is Japan’s official compendium of drug quality standards, specifications, and testing methods that ensures the safety and efficacy of medicines used in the country.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: Commentar zur Pharmacopoea Germanica
Target entity description: Commentar zur Pharmacopoea Germanica is a comprehensive pharmaceutical reference work by Hermann Hager that provides detailed explanations, annotations, and practical guidance related to the German pharmacopoeia.

• A. Certificates of Suitability to the monographs of the European Pharmacopoeia
  Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
• B. European Pharmacopoeia
  The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
• C. Pharmacopeia
  Pharmacopeia is a biotechnology company known for pioneering combinatorial chemistry and high-throughput drug discovery technologies.
• D. United States Pharmacopeia
  The United States Pharmacopeia is an official compendium that sets quality, purity, strength, and identity standards for medicines, food ingredients, and dietary supplements used in the United States and many other countries.
• E. Japanese Pharmacopoeia
  The Japanese Pharmacopoeia is Japan’s official compendium of drug quality standards, specifications, and testing methods that ensures the safety and efficacy of medicines used in the country.
• F. None of above. chosen